Aussie tech startup acquired by Pfizer for $179 million after developing an app that can ‘hear’ COVID-19
ASX-listed ResApp developed a smartphone application that studies showed could identify a COVID-19 infection from a person's cough.
The Federal Court has dismissed the Australian Competition and Consumer Commission’s allegations that pharmaceutical giant Pfizer misused …